Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L, Moreau T, Pelletier J, Lubetzki C, Clanet M; French Modafinil Study Group. Stankoff B, et al. Among authors: confavreux c. Neurology. 2005 Apr 12;64(7):1139-43. doi: 10.1212/01.WNL.0000158272.27070.6A. Neurology. 2005. PMID: 15824337 Clinical Trial.
Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis.
Brochet B, Guinot P, Orgogozo JM, Confavreux C, Rumbach L, Lavergne V. Brochet B, et al. Among authors: confavreux c. J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):360-2. doi: 10.1136/jnnp.58.3.360. J Neurol Neurosurg Psychiatry. 1995. PMID: 7897422 Free PMC article. Clinical Trial.
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
Edan G, Miller D, Clanet M, Confavreux C, Lyon-Caen O, Lubetzki C, Brochet B, Berry I, Rolland Y, Froment JC, Cabanis E, Iba-Zizen MT, Gandon JM, Lai HM, Moseley I, Sabouraud O. Edan G, et al. Among authors: confavreux c. J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):112-8. doi: 10.1136/jnnp.62.2.112. J Neurol Neurosurg Psychiatry. 1997. PMID: 9048709 Free PMC article. Clinical Trial.
Neuromyelitis optica in France: a multicenter study of 125 patients.
Collongues N, Marignier R, Zéphir H, Papeix C, Blanc F, Ritleng C, Tchikviladzé M, Outteryck O, Vukusic S, Fleury M, Fontaine B, Brassat D, Clanet M, Milh M, Pelletier J, Audoin B, Ruet A, Lebrun-Frenay C, Thouvenot E, Camu W, Debouverie M, Créange A, Moreau T, Labauge P, Castelnovo G, Edan G, Le Page E, Defer G, Barroso B, Heinzlef O, Gout O, Rodriguez D, Wiertlewski S, Laplaud D, Borgel F, Tourniaire P, Grimaud J, Brochet B, Vermersch P, Confavreux C, de Seze J. Collongues N, et al. Among authors: confavreux c. Neurology. 2010 Mar 2;74(9):736-42. doi: 10.1212/WNL.0b013e3181d31e35. Neurology. 2010. PMID: 20194912
[Etiology of multiple sclerosis].
Confavreux C, Goudable B, Moreau T. Confavreux C, et al. Rev Prat. 1991 Sep 15;41(20):1888-92. Rev Prat. 1991. PMID: 1925371 Review. French.
Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort.
Papeix C, Vukusic S, Casey R, Debard N, Stankoff B, Mrejen S, Uhry Z, Van Ganse E, Castot A, Clanet M, Lubetzki C, Confavreux C; TYSEDMUS and OFSEP Group. Papeix C, et al. Among authors: confavreux c. Neurol Neuroimmunol Neuroinflamm. 2016 Oct 28;3(6):e297. doi: 10.1212/NXI.0000000000000297. eCollection 2016 Dec. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27844037 Free PMC article.
351 results